Shareholders Reject Executive Compensation, Mandate Annual Reviews
MKTW sits 24% above its 52-week low of $13.49 on light trading volume (0.4× avg).
Summary
MarketWise shareholders rejected the advisory "Say-on-Pay" proposal for executive compensation and voted for annual reviews, signaling discontent with current pay practices.
Key Events · Corporate Governance and Compliance · MKTW
-
Shareholders Reject Executive Compensation
The advisory "Say-on-Pay" proposal for named executive officers was not approved, with 7,476,751 votes against compensation.
-
Annual Say-on-Pay Votes Approved
Stockholders approved a one-year interval for future advisory votes on executive compensation, increasing the frequency of review.
-
Director Elected
Matthew Turner was elected to serve as a Class II director until the 2029 Annual Meeting of Stockholders.
-
Auditor Ratified
Grant Thornton LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
Analysis · MKTW · Technology
Shareholders expressed significant dissatisfaction with executive compensation by rejecting the advisory "Say-on-Pay" proposal. This non-binding vote sends a clear message to management regarding their pay structures, especially following recent mixed financial results including a net loss and negative operating cash flow. The approval for annual Say-on-Pay votes means this issue will be revisited more frequently, increasing scrutiny on executive compensation.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 30.2% of the 1644 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.49%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MKTW was trading at $16.76 on NASDAQ in the Technology sector, with a market capitalization of approximately $270.7M. The 52-week trading range was $13.49 to $21.74. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.